Pill Identification: V 2090 Imprint
I cannot definitively identify the manufacturer of a pill marked "V 2090" or "2090 V" based on the provided medical evidence, as none of the sources contain pharmaceutical identification databases or specific imprint code information.
Critical Safety Considerations
You should never take any medication based solely on imprint identification without proper verification through a licensed pharmacist or healthcare provider. The unregulated drug market contains widespread counterfeit medications that may contain dangerous substances instead of the labeled drug.
Counterfeit Medication Risks
- Counterfeit tablets purchased outside regulated pharmacies frequently contain substances other than what they purport to be, with only 23.7% of expected alprazolam tablets actually containing alprazolam in one drug checking study 1
- Illicitly manufactured tablets may contain lethal combinations of substances, including designer benzodiazepines like etizolam combined with stimulants like caffeine, which has resulted in fatal overdoses 2
- Failed synthesis attempts by inexperienced clandestine chemists can produce tablets containing unintended toxic compounds rather than the intended pharmaceutical 3
Proper Identification Methods
- Contact a licensed pharmacist who has access to comprehensive pill identification databases that cross-reference imprint codes with manufacturers
- Use FDA-approved identification resources rather than attempting visual identification alone, as the current non-standardized imprint system has significant limitations in accuracy 4
- Never consume unidentified medications, especially those obtained outside legitimate pharmacy channels, as point-of-care drug checking technologies have limitations and may not detect all dangerous adulterants 1
Why This Information Isn't in Medical Guidelines
The provided evidence focuses on clinical treatment guidelines for conditions like tuberculosis, insomnia, and pain management rather than pharmaceutical identification databases. Pill identification requires specialized pharmaceutical references, not clinical practice guidelines.